Skip to content

Madrigal Pharmaceuticals, Inc. MDGL Common Stock Par Value Per Share

Common Stock Par Value Per Share at other companies

Antero Resources logo
Antero ResourcesAR
$3.17M+0.5%
Starwood Property Trust logo
Starwood Property TrustSTWD
$2.79M+5.2%
Ball Corporation logo
Ball CorporationBALL
$1.04B
CF Industries logo
CF IndustriesCF
$5.46B+11.0%
PNC Financial Services logo
PNC Financial ServicesPNC
$500K0.0%
EastGroup Properties logo
EastGroup PropertiesEGP
$0.000.0%

Other financials

Income statement

See full
Revenue$311.3M+127%
Gross profit$43.5M
Operating income-$92.7M-16.9%
Net income-$94.4M-28.9%
EPS (diluted)-$3.25-24.5%

Balance sheet

See full
Cash & equivalents$232.2M+23.1%
Total debt$377.3M+187%
Total equity$543.5M-23.5%
Total assets$1.2B+23.1%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$3.8M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.66B+64.2%
Enterprise value$11.81B+67.5%
P/S10.3×-12.1×

Profitability

See full
Gross margin96.5%
Operating margin-27.7%-12.2pp
Net margin-27.3%-12.0pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-49.3%-0.8pp
Debt / equity0.7×+0.5×
Current ratio3.5×-2.4×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s common stock par value per share.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s common stock par value per share?
Madrigal Pharmaceuticals, Inc. (MDGL) reported common stock par value per share of $0.00 in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s common stock par value per share changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s common stock par value per share?
Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.